DARPA and VUMC use high-throughput synthetic genes to hasten antibody discovery

Recent outbreaks of deadly viruses like Ebola, Zika and Monkeypox have shocked the world with their impact. In nature, the viruses typically lie dormant in their animal hosts, accruing mutations that change their genetic make-up significantly. Once an event occurs that allows the viruses to jump to humans, our immune systems are not prepared. The viruses spread rapidly, causing significant, life threatening infection, reminding us just how vulnerable we are to these diseases. In response, governmental and non-governmental agencies, as well as universities and research institutions, are racing to develop programs to identify, characterize and control these viruses before they turn into full-blown pandemics.

Read more at Accelerating Antibody Discovery Pipelines for Infectious Disease.